Literature DB >> 35912293

Brucella epidydimo-orchitis successfully treated with dual oral drug regimen: A case report with differential diagnoses of malignancy and tuberculosis.

Renad S Nahas1, Abdulsalam Alsulami2, Manar O Lashkar1, Abrar K Thabit1.   

Abstract

Brucellosis is a zoonotic disease caused by Brucella spp. When complicated, Brucella may affect any organ system, including the genitourinary system in the form of epidydimo-orchitis. Brucella orchitis is the second most common form of complicated brucellosis. The present case is for an adolescent who is otherwise healthy but presented with right testicular pain. Ultrasound imaging showed heterogeneous enlarged right testis with large heterogeneous mass and central necrosis. α-fetoprotein was normal and β-human choriogonadotropin was negative. Malignancy and tuberculosis were excluded based on histopathology and microbiology of the tissue biopsy, respectively. The history of raw dairy consumption and positive serology for B. melitensis and B. abortus established the diagnosis of Brucella epidydimo-orchitis. Treatment was successful with doxycycline and rifampin for four weeks. In pediatrics, it is important to rule out malignancy and make every attempt to avoid orchidectomy by making necessary investigations and involving infectious diseases consultation.
© 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington.

Entities:  

Keywords:  Brucella Epidydimo-orchitis; Brucella orchitis; Brucellosis; Testicles; Testis

Year:  2022        PMID: 35912293      PMCID: PMC9334919          DOI: 10.1016/j.radcr.2022.07.012

Source DB:  PubMed          Journal:  Radiol Case Rep        ISSN: 1930-0433


Introduction

Brucellosis is a zoonotic disease commonly known as Malta fever. Brucellosis is an endemic disease in the Mediterranean region, Latin America, and the Middle East. Brucellosis is caused by Brucella pp., which are Gram-negative coccobacilli, non-sporing, and non-motile bacteria. There are four Brucella species known to cause disease in human, including B. abortus, B. melitensis, B. suis, and B. canis [1]. The most common way of brucellosis acquisition is through consumption of unpasteurized/raw dairy products and direct contact with infected livestock animals [2]. Brucellosis may manifest with fever, night sweats, headache, anorexia, and weight loss. When complicated, Brucella may affect any organ system, including osteoarticular, genitourinary, liver, and cardiovascular systems [3]. Brucella epidydimo-orchitis is the second most common form of complicated brucellosis, which can affect adults and pediatrics alike. Patients tend to present with urinary symptoms, scrotal pain, and swelling [4]. Brucella epidydimo-orchitis is treated for 6 weeks with 2 to 3 different antibiotics, which can include doxycycline, rifampin, trimethoprim/sulfamethoxazole, or ciprofloxacin [5, 6]. Only a few published cases of Brucella epidydimo-orchitis were identified in the literature. However, all the published cases were of adult patients. Therefore, this report describes an interesting successfully treated case of Brucella orchitis in an adolescent. This report was approved by the Biomedical Research Ethics Unit who also waived the requirement for patient consent.

Case

A 17-year-old male, previously healthy was seen in the outpatient clinic complaining of right testicular pain. He was afebrile and hemodynamically stable. Initial routine laboratory studies including complete blood count, urine analysis, urine culture, renal function, and electrolytes were normal. An ultrasound was obtained and showed a heterogeneous enlarged right testis measuring 5.22 × 3.4 × 3.9 cm with large heterogeneous mass and central necrosis measuring 4.6 × 2.7 cm (Fig. 1, Fig. 2, Fig. 3, Fig. 4). The right-sided venous plexus measured 0.28 cm at rest and Valsalva 0.39 cm. α-fetoprotein was normal at 1.35 (normal 0-5.8) and β-human choriogonadotropin was negative. A testicular biopsy was done under general anesthesia with plan for possible orchidectomy due to concerns for malignancy and tuberculosis after worsening of his symptoms. The frozen biopsy was negative for malignancy, so core biopsy was sent to pathology. Orchidectomy was not done. The biopsy revealed predominantly non-caseating granulomatous epidydimo-orchitis with focus of necrosis, and the biopsy was negative for malignancy. Acid fast bacilli smear and culture of the biopsied tissue showed no mycobacteria. Blood polymerase chain reaction testing for Mycobacterium tuberculosis complex was also negative. Histochemistry stain was also negative for fungi.
Fig. 1

Grayscale ultrasound of the scrotum showed right testicular enlargement secondary to the mass.

Fig. 2

Grayscale ultrasound of the right testis in long axis showing the parenchymal heterogeneous mass lesion with areas of cystic changes/necrosis. Note the peripheral normal testicular tissue.

Fig. 3

Doppler ultrasound of the same testis showing significant perilesional hyperemia denoting severe inflammation.

Fig. 4

Doppler ultrasound image showing the severe hyperemia also involving the epididymis, in keeping with epidydimo-orchitis.

Grayscale ultrasound of the scrotum showed right testicular enlargement secondary to the mass. Grayscale ultrasound of the right testis in long axis showing the parenchymal heterogeneous mass lesion with areas of cystic changes/necrosis. Note the peripheral normal testicular tissue. Doppler ultrasound of the same testis showing significant perilesional hyperemia denoting severe inflammation. Doppler ultrasound image showing the severe hyperemia also involving the epididymis, in keeping with epidydimo-orchitis. The patient was referred to the infectious disease clinic, and Brucella serology were ordered given history of raw milk and cheese ingestion 3 weeks prior to the initial presentation. Serum Brucella antibody titers were 1:640 for B. melitensis and 1:160 for B. abortus. The diagnosis of Brucella epidydimo-orchitis was made. Hence, the patient was started on doxycycline 100 mg orally every 12 hours and rifampin 600 mg orally once daily based on body weight of 40 kg. After four months of therapy, the patient's right testis reversed back to normal size and titers dropped to 1:320 for B. melitensis and 1:80 for B. abortus. Serology was repeated 14 months after initial presentation and showed antibody titers of 1:40 for both species. No adverse effect of therapy was reported.

Discussion

Brucellosis remains a common zoonotic disease in the Middle East. It affects people of all ages with incidence of 10%-11% in endemic areas; however, 11.56% of cases occur in patients under 14 years of age [2]. Direct contact with infected animals, intake of raw dairy products, and inhalation of aerosols are all ways for infection to spread to people [8]. The most common genitourinary consequences of brucellosis in males are orchitis and epididymitis. A case series by Fatani et al included a case of Brucella epidydimo-orchitis in a 44-year-old man who complained of scrotal pain and fever. The patient was successfully treated with ceftriaxone, doxycycline, and rifampin [9]. A study by Akıncı and colleague included 17 Brucella epidydimo-orchitis patients. Scrotal discomfort and edema were the most prevalent symptoms. Antibiotic regimens varied among patients where most patients (10/17) received rifampin plus doxycycline. Antibiotic treatment showed clinical improvement in 15 of 17 of the patients. In 2 cases, orchidectomy was indicated. Relapse occurred in only one patient after 3 months of antibiotic therapy [7]. In a retrospective study of 28 patients with Brucella epidydimo-orchitis, the most reported symptoms were fever, testicular pain, and swelling. All but 3 patients were successfully treated with rifampin, doxycycline, and streptomycin combinations. Orchidectomy was performed on 2 of the 3 treatment-resistant patients [10]. Navarro-Martinez et al included 59 cases of Brucella epidydimo-orchitis in a retrospective study with patients’ average age of 34 years. Of the included patients, most patients received a combination of doxycycline plus either streptomycin, netilmicin or gentamicin. Testicular abscess was drained in 2 patients, and orchidectomy was performed in 3 others [5]. Fentes et al reported a 37-year-old male with fever, scrotal pain and swelling who was diagnosed with Brucella epidydimo-orchitis based on blood culture and serologic test. The patient was successfully treated with doxycycline for 6 weeks and intramuscular streptomycin for 3 weeks [11]. Another case from Australia of an 18-year-old patient who presented with fever, dysuria, urethral discharge, and loss of appetite. B. melitensis was isolated from blood culture on the 4th day of hospitalization confirming the diagnosis of Brucella epidydimo-orchitis. During his initial presentation, the patient was given a single dose of azithromycin 1 g and gentamicin 320 mg. However, once the diagnosis of brucellosis was established, he was switched to a 7-day course of intravenous gentamicin and a 6-week course of doxycycline for 16 weeks. At the 6-week follow-up, the patient achieved a complete recovery [12]. In our report, the patient had complicated brucellosis and was successfully treated with dual therapy of doxycycline and rifampin. The recommended regimen by the World Health Organization (WHO) for acute uncomplicated brucellosis in adults and children older than 8 years is either an aminoglycoside for 7 days with doxycycline 100 mg orally twice daily for 6 weeks or doxycycline 100 mg orally twice daily plus rifampin 600-900 mg orally once daily for 6 weeks [3]. To date, there is no specific regimen recommended by WHO for epidydimo-orchitis; hence, the same regimen of uncomplicated brucellosis could be used for treatment [3].

Conclusion

Epidydimo-orchitis is a rare brucellosis complication. Therefore, it is important to rule out malignancy and make every attempt to avoid orchidectomy by making necessary investigations and involving infectious diseases consultation. Unpasteurized/raw dairy products and direct contact with diseased livestock animals are the most prevalent ways to contract brucellosis. There is no specific recommendation for Brucella epidydimo-orchitis treatment by the WHO. Nonetheless, based on findings from this case and results of previously published cases, Brucella epidydimo-orchitis can be treated using the same regimens used for uncomplicated brucellosis.
  11 in total

Review 1.  [Brucella orchyoepididymitis: case report].

Authors:  Daniel Pérez Fentes; Miguel Blanco Parra; María Alende Sixto; Lema Grille José; Antonio Cimadevila García; Valentín Toucedo Caamaño; Pedro Lamas Cederrón; Manuel Villar Núñez
Journal:  Arch Esp Urol       Date:  2005-09       Impact factor: 0.436

2.  A complication of brucellosis: epididymoorchitis.

Authors:  Esragül Akinci; Hürrem Bodur; Mustafa Aydin Cevik; Ayşe Erbay; Selim Sirri Eren; Ipek Ziraman; Neriman Balaban; Ali Atan; Gülüşan Ergül
Journal:  Int J Infect Dis       Date:  2005-12-19       Impact factor: 3.623

3.  Dual versus triple therapy for uncomplicated brucellosis: A retrospective cohort study.

Authors:  Rawan O Al-Madfaa; Mai A Alalawi; Lana O Basudan; Shahad F Alhejaili; Khalid Eljaaly; Tariq A Madani; Abrar K Thabit
Journal:  J Infect Dev Ctries       Date:  2020-12-31       Impact factor: 0.968

4.  Acute epididymo-orchitis from brucellosis melitensis in Australia.

Authors:  Christopher Chi Kit Ip; Khrisna Tumali; Ivan M Hoh; Arun Arunasalam
Journal:  BMJ Case Rep       Date:  2019-07-10

5.  Epididymoorchitis due to Brucella mellitensis: a retrospective study of 59 patients.

Authors:  A Navarro-Martínez; J Solera; J Corredoira; J L Beato; E Martínez-Alfaro; M Atiénzar; J Ariza
Journal:  Clin Infect Dis       Date:  2001-11-06       Impact factor: 9.079

6.  Conservative treatment for Brucella testicular abscesses: A case report and literature review.

Authors:  Sakher Tahaineh; Rawan Abu Mughli; Hanan I Hakami; Mohamad I Al-Faham
Journal:  Can Urol Assoc J       Date:  2015-09-09       Impact factor: 1.862

Review 7.  Brucellar epididymo-orchitis: a retrospective multicenter study of 28 cases and review of the literature.

Authors:  Umit Savasci; Murat Zor; Ahmet Karakas; Emsal Aydin; Ramazan Kocaaslan; N Cem Oren; Omer Coskun; Vedat Turhan; H Cem Gul; A Fuat Cicek; Emin Aydur; Can Polat Eyigun
Journal:  Travel Med Infect Dis       Date:  2014-10-25       Impact factor: 6.211

Review 8.  Systematic review of brucellosis in the Middle East: disease frequency in ruminants and humans and risk factors for human infection.

Authors:  I I Musallam; M N Abo-Shehada; Y M Hegazy; H R Holt; F J Guitian
Journal:  Epidemiol Infect       Date:  2015-10-28       Impact factor: 2.451

9.  Ceftriaxone use in brucellosis: A case series.

Authors:  Daniah F Fatani; Walaa A Alsanoosi; Mazen A Badawi; Abrar K Thabit
Journal:  IDCases       Date:  2019-09-05

Review 10.  Pediatric brucellosis. An update review for the new millennium.

Authors:  Elham E Bukhari
Journal:  Saudi Med J       Date:  2018-04       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.